Literature DB >> 21107124

Therapy for nystagmus.

Matthew J Thurtell1, R John Leigh.   

Abstract

Pathological forms of nystagmus and their visual consequences can be treated using pharmacological, optical, and surgical approaches. Acquired periodic alternating nystagmus improves following treatment with baclofen, and downbeat nystagmus may improve following treatment with aminopyridines. Gabapentin and memantine are helpful in reducing acquired pendular nystagmus due to multiple sclerosis. Ocular oscillations in oculopalatal tremor may also improve following treatment with memantine or gabapentin. The infantile nystagmus syndrome (INS) may have only a minor impact on vision if "foveation periods" are well developed, but symptomatic patients may benefit from treatment with gabapentin, memantine, or base-out prisms to induce convergence. Several surgical therapies are also reported to improve INS, but selection of the optimal treatment depends on careful evaluation of visual acuity and nystagmus intensity in various gaze positions. Electro-optical devices are a promising and novel approach for treating the visual consequences of acquired forms of nystagmus.

Entities:  

Mesh:

Year:  2010        PMID: 21107124     DOI: 10.1097/WNO.0b013e3181e7518f

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  10 in total

1.  Treatment of nystagmus.

Authors:  Matthew J Thurtell; R John Leigh
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

2.  Crossover trial of gabapentin and memantine as treatment for acquired nystagmus.

Authors:  Matthew J Thurtell; Anand C Joshi; Alice C Leone; Robert L Tomsak; Gregory S Kosmorsky; John S Stahl; R John Leigh
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

Review 3.  [Rare tremor syndromes].

Authors:  J S Becktepe; F Goevert; G Deuschl
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 4.  Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.

Authors:  Michael Strupp; Matthew J Thurtell; Aasef G Shaikh; Thomas Brandt; David S Zee; R John Leigh
Journal:  J Neurol       Date:  2011-04-02       Impact factor: 4.849

Review 5.  Interventions for eye movement disorders due to acquired brain injury.

Authors:  Fiona J Rowe; Kerry Hanna; Jennifer R Evans; Carmel P Noonan; Marta Garcia-Finana; Caroline S Dodridge; Claire Howard; Kathryn A Jarvis; Sonia L MacDiarmid; Tallat Maan; Lorraine North; Helen Rodgers
Journal:  Cochrane Database Syst Rev       Date:  2018-03-05

Review 6.  The treatment methods for post-stroke visual impairment: A systematic review.

Authors:  Kerry Louise Hanna; Lauren Rachel Hepworth; Fiona J Rowe
Journal:  Brain Behav       Date:  2017-04-06       Impact factor: 2.708

Review 7.  Infantile nystagmus: an optometrist's perspective.

Authors:  Asma Aa Zahidi; J Margaret Woodhouse; Jonathan T Erichsen; Matt J Dunn
Journal:  Clin Optom (Auckl)       Date:  2017-09-25

Review 8.  Management of nystagmus in children: a review of the literature and current practice in UK specialist services.

Authors:  J E Self; M J Dunn; J T Erichsen; I Gottlob; H J Griffiths; C Harris; H Lee; J Owen; J Sanders; F Shawkat; M Theodorou; J P Whittle
Journal:  Eye (Lond)       Date:  2020-01-09       Impact factor: 3.775

9.  Abnormally Small Neuromuscular Junctions in the Extraocular Muscles From Subjects With Idiopathic Nystagmus and Nystagmus Associated With Albinism.

Authors:  Linda K McLoon; Christy L Willoughby; Jill S Anderson; Erick D Bothun; David Stager; Joost Felius; Helena Lee; Irene Gottlob
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

10.  Vision In Stroke cohort: Profile overview of visual impairment.

Authors:  Fiona J Rowe
Journal:  Brain Behav       Date:  2017-10-06       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.